PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| α,α-dimethylphenethyl acetate | 205-781-3 | 151-05-3 | - | - | 1 | - | - | - | - | - | - | Details |
| α,α-dimethylphenethyl butyrate | 233-221-8 | 10094-34-5 | - | - | 1 | - | - | - | - | - | - | Details |
| β-Alanine, N-(2-carboxyethyl)-, N-coco alkyl derivs., disodium salts | 290-476-8 | 90170-43-7 | - | - | 1 | - | 1 | - | - | - | - | Details |
| β-Alanine, N-C8-18-alkyl derivs., monopotassium salts | 290-475-2 | 90170-42-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| γ-butyrolactone | 202-509-5 | 96-48-0 | - | - | 1 | - | - | 1 | - | - | - | Details |
| δ-valerolactone | 208-807-1 | 542-28-9 | - | - | 1 | - | - | - | - | - | - | Details |
| ε-caprolactam | 203-313-2 | 105-60-2 | - | - | 1 | - | - | - | - | - | - | Details |
| ε-Caprolactone, oligomeric reaction products with propylidynetrimethanol | 500-099-5 | 37625-56-2 | - | - | 1 | - | - | - | - | - | - | Details |
| λ²-iron(2+) lithium(1+) phosphate | 476-700-9 | 1199808-36-0 | - | - | 1 | - | - | - | - | - | - | Details |
| ((3-(sec-butyl)-4-(decyloxy)phenyl)methanetriyl)tribenzene | 801-941-7 | 1404190-37-9 | - | - | 2 | - | 1 | - | - | - | - | Details |